Literature DB >> 25456875

Relation of dyspnea severity on admission for acute heart failure with outcomes and costs.

Robert J Mentz1, Xiaojuan Mi2, Puza P Sharma3, Laura G Qualls2, Adam D DeVore4, Katherine Waltman Johnson3, Gregg C Fonarow5, Lesley H Curtis4, Adrian F Hernandez4.   

Abstract

Hospitalization for heart failure (HF) is frequently related to dyspnea, yet associations among dyspnea severity, outcomes, and health care costs are unknown. The aim of this study was to describe the characteristics of patients hospitalized for acute HF by dyspnea severity and to examine associations among dyspnea severity, outcomes, and costs. Registry data for patients hospitalized for HF were linked with Medicare claims to evaluate dyspnea and outcomes in patients ≥65 years of age. We classified patients by patient-reported dyspnea severity at admission. Outcomes included length of stay, mortality 30 days after admission, days alive and out of the hospital, readmission, and Medicare payments 30 days after discharge. Of 48,616 patients with acute HF and dyspnea, 4,022 (8.3%) had dyspnea with moderate activity, 19,619 (40.3%) with minimal activity, and 24,975 (51.4%) at rest. Patients with dyspnea with minimal activity or at rest had greater co-morbidities, including renal insufficiency. Greater severity of baseline dyspnea was associated with mortality (moderate activity, 6.3%; minimal activity, 7.6%; at rest, 11.6%) and HF readmission (7.2%, 9.0%, and 9.4%). After multivariate adjustment, dyspnea at rest was associated with greater 30-day mortality and HF readmission, fewer days alive and out of the hospital, longer length of stay, and higher Medicare payments compared with dyspnea with moderate activity. In conclusion, dyspnea at rest on presentation was associated with greater mortality, readmission, length of stay, and health care costs in patients hospitalized with acute HF.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25456875      PMCID: PMC4262730          DOI: 10.1016/j.amjcard.2014.09.048

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

1.  What are the costs of heart failure?

Authors:  Frieder Braunschweig; Martin R Cowie; Angelo Auricchio
Journal:  Europace       Date:  2011-05       Impact factor: 5.214

2.  Acute heart failure syndromes: current state and framework for future research.

Authors:  Mihai Gheorghiade; Faiez Zannad; George Sopko; Liviu Klein; Ileana L Piña; Marvin A Konstam; Barry M Massie; Edmond Roland; Shari Targum; Sean P Collins; Gerasimos Filippatos; Luigi Tavazzi
Journal:  Circulation       Date:  2005-12-20       Impact factor: 29.690

3.  Effect of nesiritide in patients with acute decompensated heart failure.

Authors:  C M O'Connor; R C Starling; A F Hernandez; P W Armstrong; K Dickstein; V Hasselblad; G M Heizer; M Komajda; B M Massie; J J V McMurray; M S Nieminen; C J Reist; J L Rouleau; K Swedberg; K F Adams; S D Anker; D Atar; A Battler; R Botero; N R Bohidar; J Butler; N Clausell; R Corbalán; M R Costanzo; U Dahlstrom; L I Deckelbaum; R Diaz; M E Dunlap; J A Ezekowitz; D Feldman; G M Felker; G C Fonarow; D Gennevois; S S Gottlieb; J A Hill; J E Hollander; J G Howlett; M P Hudson; R D Kociol; H Krum; A Laucevicius; W C Levy; G F Méndez; M Metra; S Mittal; B-H Oh; N L Pereira; P Ponikowski; W H W Tang; W H Wilson; S Tanomsup; J R Teerlink; F Triposkiadis; R W Troughton; A A Voors; D J Whellan; F Zannad; R M Califf
Journal:  N Engl J Med       Date:  2011-07-07       Impact factor: 91.245

4.  Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study.

Authors:  Marco Metra; John G Cleland; Beth Davison Weatherley; Howard C Dittrich; Michael M Givertz; Barry M Massie; Christopher M O'Connor; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Gad Cotter
Journal:  Eur J Heart Fail       Date:  2010-03-12       Impact factor: 15.534

5.  Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study.

Authors:  Marco Metra; Christopher M O'Connor; Beth A Davison; John G F Cleland; Piotr Ponikowski; John R Teerlink; Adriaan A Voors; Michael M Givertz; George A Mansoor; Daniel M Bloomfield; Gang Jia; Paul DeLucca; Barry Massie; Howard Dittrich; Gad Cotter
Journal:  Eur Heart J       Date:  2011-03-08       Impact factor: 29.983

6.  Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow.

Authors:  Justin A Ezekowitz; Adrian F Hernandez; Christopher M O'Connor; Randall C Starling; Guy Proulx; Mason H Weiss; Jeffrey A Bakal; Robert M Califf; John J V McMurray; Paul W Armstrong
Journal:  J Am Coll Cardiol       Date:  2012-04-17       Impact factor: 24.094

Review 7.  A review of dyspnea in acute heart failure syndromes.

Authors:  Ryenn L West; Adrian F Hernandez; Christopher M O'Connor; Randall C Starling; Robert M Califf
Journal:  Am Heart J       Date:  2010-08       Impact factor: 4.749

8.  Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study.

Authors:  Marco Metra; John R Teerlink; G Michael Felker; Barry H Greenberg; Gerasimos Filippatos; Piotr Ponikowski; Sam L Teichman; Elaine Unemori; Adriaan A Voors; Beth Davison Weatherley; Gad Cotter
Journal:  Eur J Heart Fail       Date:  2010-08-22       Impact factor: 15.534

9.  Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

Authors:  Christopher M O'Connor; William T Abraham; Nancy M Albert; Robert Clare; Wendy Gattis Stough; Mihai Gheorghiade; Barry H Greenberg; Clyde W Yancy; James B Young; Gregg C Fonarow
Journal:  Am Heart J       Date:  2008-10       Impact factor: 4.749

10.  Linking inpatient clinical registry data to Medicare claims data using indirect identifiers.

Authors:  Bradley G Hammill; Adrian F Hernandez; Eric D Peterson; Gregg C Fonarow; Kevin A Schulman; Lesley H Curtis
Journal:  Am Heart J       Date:  2009-06       Impact factor: 4.749

View more
  13 in total

Review 1.  Pathophysiology and clinical evaluation of acute heart failure.

Authors:  Robert J Mentz; Christopher M O'Connor
Journal:  Nat Rev Cardiol       Date:  2015-09-15       Impact factor: 32.419

Review 2.  Patient selection in heart failure with preserved ejection fraction clinical trials.

Authors:  Jacob P Kelly; Robert J Mentz; Alexandre Mebazaa; Adriaan A Voors; Javed Butler; Lothar Roessig; Mona Fiuzat; Faiez Zannad; Bertram Pitt; Christopher M O'Connor; Carolyn S P Lam
Journal:  J Am Coll Cardiol       Date:  2015-04-28       Impact factor: 24.094

3.  Psychometric Analysis of the Heart Failure Somatic Perception Scale as a Measure of Patient Symptom Perception.

Authors:  Corrine Y Jurgens; Christopher S Lee; Barbara Riegel
Journal:  J Cardiovasc Nurs       Date:  2017 Mar/Apr       Impact factor: 2.083

4.  Identifying unique profiles of perceived dyspnea burden in heart failure.

Authors:  Kenneth M Faulkner; Corrine Y Jurgens; Quin E Denfeld; Karen S Lyons; Jessica Harman Thompson; Christopher S Lee
Journal:  Heart Lung       Date:  2020-05-18       Impact factor: 2.210

5.  Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial.

Authors:  Andrew P Ambrosy; Lukasz P Cerbin; Paul W Armstrong; Javed Butler; Adrian Coles; Adam D DeVore; Mark E Dunlap; Justin A Ezekowitz; G Michael Felker; Marat Fudim; Stephen J Greene; Adrian F Hernandez; Christopher M O'Connor; Philip Schulte; Randall C Starling; John R Teerlink; Adriaan A Voors; Robert J Mentz
Journal:  JACC Heart Fail       Date:  2017-01       Impact factor: 12.035

6.  Patterns and predictors of dyspnoea following left ventricular assist device implantation.

Authors:  Kenneth M Faulkner; Corrine Y Jurgens; Quin E Denfeld; Christopher V Chien; Jessica Harman Thompson; Jill M Gelow; Kathleen L Grady; Christopher S Lee
Journal:  Eur J Cardiovasc Nurs       Date:  2022-10-14       Impact factor: 3.593

7.  Dyspnea in Community-Dwelling Older Persons: A Multifactorial Geriatric Health Condition.

Authors:  Brienne Miner; Mary E Tinetti; Peter H Van Ness; Ling Han; Linda Leo-Summers; Anne B Newman; Patty J Lee; Carlos A Vaz Fragoso
Journal:  J Am Geriatr Soc       Date:  2016-08-22       Impact factor: 5.562

8.  Differences in health care use and outcomes by the timing of in-hospital worsening heart failure.

Authors:  Lauren B Cooper; Bradley G Hammill; Puza P Sharma; Adam D DeVore; Robert J Mentz; Gregg C Fonarow; Peter S Pang; Lesley H Curtis; Adrian F Hernandez
Journal:  Am Heart J       Date:  2015-09-11       Impact factor: 4.749

9.  Resource Utilization in Pediatric Patients Supported With Ventricular Assist Devices in the United States: A Multicenter Study From the Pediatric Interagency Registry for Mechanically Assisted Circulatory Support and the Pediatric Health Information System.

Authors:  Joseph W Rossano; Ryan S Cantor; Dingwei Dai; Pirouz Shamszad; Yuan-Shung Huang; Matthew Hall; Kimberly Y Lin; R Erik Edens; P Eugene Parrino; James K Kirklin
Journal:  J Am Heart Assoc       Date:  2018-06-01       Impact factor: 5.501

Review 10.  Should we overcome the resistance to bioelectrical impedance in heart failure?

Authors:  Stephen J Hankinson; Charles H Williams; Van-Khue Ton; Stephen S Gottlieb; Charles C Hong
Journal:  Expert Rev Med Devices       Date:  2020-07-13       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.